Impact of physicochemical and structural properties on the pharmacokinetics of a series of alpha1L-adrenoceptor antagonists.
第一作者:
Alison,Betts
第一单位:
Pfizer Global Research and Development, Department of Pharmacokinetics, Dynamics and Metabolism, Sandwich, Kent, United Kingdom. alison.betts@pfizer.com
作者:
医学主题词
青少年(Adolescent);肾上腺素能α-1受体拮抗剂(Adrenergic alpha-1 Receptor Antagonists);肾上腺素能α拮抗剂(Adrenergic alpha-Antagonists);成年人(Adult);动物(Animals);吖庚因类(Azepines);血蛋白质类(Blood Proteins);交叉研究(Cross-Over Studies);狗(Dogs);药物评价, 临床前(Drug Evaluation, Preclinical);肝细胞(Hepatocytes);人类(Humans);异喹啉类(Isoquinolines);肝(Liver);男(雄)性(Male);代谢清除率(Metabolic Clearance Rate);微粒体, 肝(Microsomes, Liver);中年人(Middle Aged);分子结构(Molecular Structure);蛋白质结合(Protein Binding);喹唑啉类(Quinazolines);喹啉类(Quinolines);大鼠(Rats);大鼠, Sprague-Dawley(Rats, Sprague-Dawley);单盲法(Single-Blind Method);磺胺类(Sulfonamides)
DOI
10.1124/dmd.107.015180
PMID
17502340
发布时间
2025-02-12
- 浏览25
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



